CORT Q1 2020 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$93M+43.8% YoY

Gross Profit

$91M98.0% margin

Operating Income

$38M40.4% margin

Net Income

$30M32.2% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+6.1%

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$33M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$445M

Total Liabilities

$36M

Stockholders' Equity

$409M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93M	$65M	+43.8%
Gross Profit	$91M	$64M	+43.7%
Operating Income	$38M	$19M	+98.9%
Net Income	$30M	$18M	+64.5%